Patel V - Search Results

1

Modification of treatment-sequence model with a customizable number of treatments to better reflect contemporary and future clinical practice in moderate to severe psoriasis.

van de Wetering G, Ignacio T, Dhanda D, Patel V, Zhang Y, Zhuo J. van de Wetering G, et al. Among authors: patel v. J Med Econ. 2022 Jan-Dec;25(1):421-427. doi: 10.1080/13696998.2022.2051912. J Med Econ. 2022. PMID: 35297738 Free article.

2

Comparison of infection-related hospitalization risk and costs in tumor necrosis factor inhibitor-experienced patients with rheumatoid arthritis (RA) treated with abatacept or other targeted disease-modifying anti-rheumatic drugs (tDMARDs).

Paul D, Patil D, McDonald L, Patel V, Lobo F. Paul D, et al. Among authors: patel v. J Med Econ. 2020 Sep;23(9):1025-1031. doi: 10.1080/13696998.2020.1772271. Epub 2020 Jun 13. J Med Econ. 2020. PMID: 32427547 Free article.

3

Risk and cost of infection-related hospitalizations in medicare beneficiaries with comorbid rheumatoid arthritis treated with abatacept versus other targeted disease-modifying anti-rheumatic drugs.

Patel V, Pulungan Z, Shah A, Kambhampati M, Lobo F, Petrilla A. Patel V, et al. J Med Econ. 2021 Jan-Dec;24(1):299-307. doi: 10.1080/13696998.2021.1881525. J Med Econ. 2021. PMID: 33502940 Free article.

4

Prospective cohort study of psoriatic arthritis risk in patients with psoriasis in a real-world psoriasis registry.

Ogdie A, Harrison RW, McLean RR, Lin TC, Lebwohl M, Strober BE, Zhuo J, Patel V, Mease PJ. Ogdie A, et al. Among authors: patel v. J Am Acad Dermatol. 2022 Dec;87(6):1303-1311. doi: 10.1016/j.jaad.2022.07.060. Epub 2022 Aug 17. J Am Acad Dermatol. 2022. PMID: 35987397 Free article.

5

Cost per response analysis of deucravacitinib versus apremilast and first-line biologics among patients with moderate to severe plaque psoriasis in the United States.

Park SH, Lambton M, Schmier J, Hovland S, Wittstock K, Patel V. Park SH, et al. Among authors: patel v. J Dermatolog Treat. 2024 Dec;35(1):2366503. doi: 10.1080/09546634.2024.2366503. Epub 2024 Jun 24. J Dermatolog Treat. 2024. PMID: 38914425 Free article.

6

The Association Between Patient-Reported Disease Burden and Treatment Switching in Patients with Plaque Psoriasis Treated with Nonbiologic Systemic Therapy.

Patel V, Park SH, Zhong Y, Sima AP, Zhuo J, Roberts-Toler C, Becker B, Hovland S, Strober B. Patel V, et al. Psoriasis (Auckl). 2024 Nov 28;14:167-174. doi: 10.2147/PTT.S478352. eCollection 2024. Psoriasis (Auckl). 2024. PMID: 39624651 Free PMC article.

7

Treatment Patterns for Targeted Therapies, Non-Targeted Therapies, and Drug Holidays in Patients with Psoriasis.

Armstrong A, Xia Q, John AR, Patel V, Seigel L. Armstrong A, et al. Among authors: patel v. Dermatol Ther (Heidelb). 2022 Sep;12(9):2087-2103. doi: 10.1007/s13555-022-00775-1. Epub 2022 Aug 10. Dermatol Ther (Heidelb). 2022. PMID: 35947341 Free PMC article.

8

Economic Burden of Comorbidities in Patients with Psoriasis in the USA.

Wu JJ, Suryavanshi M, Davidson D, Patel V, Jain A, Seigel L. Wu JJ, et al. Among authors: patel v. Dermatol Ther (Heidelb). 2023 Jan;13(1):207-219. doi: 10.1007/s13555-022-00832-9. Epub 2022 Nov 19. Dermatol Ther (Heidelb). 2023. PMID: 36402940 Free PMC article.

9

Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque Psoriasis.

Armstrong AW, Park SH, Patel V, Hogan M, Wang WJ, Davidson D, Chirikov V. Armstrong AW, et al. Among authors: patel v. Dermatol Ther (Heidelb). 2023 Nov;13(11):2589-2603. doi: 10.1007/s13555-023-00977-1. Epub 2023 Jul 31. Dermatol Ther (Heidelb). 2023. PMID: 37525000 Free PMC article.

10

Evaluating Treatment Choice in Patients with Moderate to Severe Psoriasis in the United States: Results from a US Patient Survey.

Armstrong AW, Jayade S, Rege S, Joshi N, Patel V, Kalirai S, Wolin D, Boyle K, Patel D, Seigel L. Armstrong AW, et al. Among authors: patel v, patel d. Dermatol Ther (Heidelb). 2024 Feb;14(2):421-439. doi: 10.1007/s13555-023-01089-6. Epub 2024 Jan 22. Dermatol Ther (Heidelb). 2024. PMID: 38252376 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,182 results

Search Page

Filters